Memantine Hydrochloride (HCL)
Sold under the brand name Namenda®, memantine hydrochloride (HCl) is a drug approved to treat moderate-to-severe Alzheimer's disease. The medication is sold in tablet and oral solution (liquid) form. It is usually taken twice a day, although at first, it is generally taken once a day.
In clinical studies, people taking memantine had a slower rate of decline in cognitive function ("thinking" functions, such as memory, language, and social interaction), compared to people taking a placebo (a "sugar pill" with no active ingredients). People who took it were also better able to perform their daily activities of living, such as bathing, dressing, eating, and shopping, compared to those taking the placebo.
Some of the most common reactions to this product include:
(Click Memantine to learn more. This article provides a more in-depth discussion, explaining how this prescription medicine works, available strengths, and how to ensure the effectiveness of each dose.)